Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
26 11 2021
Historique:
received: 01 06 2021
revised: 15 10 2021
accepted: 18 10 2021
pubmed: 7 11 2021
medline: 27 1 2022
entrez: 6 11 2021
Statut: ppublish

Résumé

Immunocompromised patients are at high-risk for severe influenza and invasive pneumococcal diseases (IPD). Despite the French Public Health Council (FPHC) and the 7th European Conference on Infections in Leukaemia (ECIL7) recommendations, vaccination coverage remains insufficient. This study aimed to estimate the coverage and determinants of influenza, pneumococcal and diphtheria-tetanus-poliomyelitis (dTP) vaccinations in hematological patients underlying chemotherapy. A survey was distributed to all patients of the hematology day hospital assessing vaccine uptakes and general opinion about vaccination. Vaccine uptakes were collected from medical and vaccination records; knowledge of and attitudes towards vaccinations in immunocompromised patients were evaluated for each general practitioner (GP) by phone call. Adequacy between vaccine uptakes and indication or not to vaccinate according to ECIL7 guidelines was assessed. Factors associated with vaccine uptakes were assessed by multivariate logistic regression. Among 145 patients, 66 % were aged 65 years or older, 40 % were followed for lymphoma and 38 % for multiple myeloma, 39 % were treated with anti-CD20 antibodies. Vaccination coverage was suboptimal for influenza (45-56 %), dTP (44 %) and IPD (16-19 %) regardless of the guidelines followed, with a wide variation in rates by information source (19-76 %). Adequacy rate with ECIL7 recommendations were 63 % and 87 % for influenza and IPD respectively. Information of patients on specific vaccinations was positively associated with flu and IPD vaccinations, as well as favorable attitude toward vaccination and age ≥ 65 years for flu vaccination, and recommendation by hematologist for pneumococcal vaccination. Despite vaccination opportunities, the complexity of these specific recommendations and the lack of communication between the health actors could explain the suboptimal vaccination coverage in this high-risk population. A proactive attitude of all actors in the city and hospital, including better patient information and a personalized and evolving vaccination schedule to help GPs to coordinate vaccination would allow to improve vaccine coverage.

Identifiants

pubmed: 34740475
pii: S0264-410X(21)01369-4
doi: 10.1016/j.vaccine.2021.10.040
pii:
doi:

Substances chimiques

Influenza Vaccines 0
Pneumococcal Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7036-7043

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alix Pierron (A)

Infectious Diseases Unit, Besancon University Hospital, Besancon, France.

Fabienne Bozon (F)

Infectious Diseases Unit, Besancon University Hospital, Besancon, France.

Ana Berceanu (A)

Hematology Unit, Besancon University Hospital, Besancon, France.

Jean Fontan (J)

Hematology Unit, Besancon University Hospital, Besancon, France.

Annie Brion (A)

Hematology Unit, Besancon University Hospital, Besancon, France.

Erick Deconinck (E)

Hematology Unit, Besancon University Hospital, Besancon, France.

Catherine Chirouze (C)

Infectious Diseases Unit, Besancon University Hospital, Besancon, France.

Anne-Sophie Brunel (AS)

Infectious Diseases Unit, Besancon University Hospital, Besancon, France. Electronic address: asbrunel@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH